Clinical Trials Browser

Terminated × OTHER × Radium-223 × Clear all

NCT03208712 2018-10-24

Radium-223 and Atezolizumab in Patients With Urothelial Carcinoma With Bone Metastases Who Have Had Disease Progression After Platinum-Based Chemotherapy

Phase EARLY_PHASE1 Terminated

Carcinoma, Transitional Cell